Published on
Dec 27, 2017
Melinta: Acquisition As Growth Strategy
Background If we accept that all drugs have a pricing issue (yes even generics, where there seems to be a race to lower prices to steal market share) and that the anti-infectives market is unconsolidated, we can argue that there is a great deal of …
Source:
Seeking Alpha
-
Neutral
